This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Axcella Health Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Karen Lavery
Introduction
Karen Lavery is a notable inventor based in Franklin, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of post-acute sequelae of COVID-19. Her work focuses on the development of amino acid compositions that can aid in recovery from this condition.
Latest Patents
Karen Lavery holds 1 patent for her invention titled "Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19." This patent discloses pharmaceutical compositions comprising amino acid entities and outlines methods for treating individuals suffering from the lingering effects of COVID-19. The compositions are designed to be administered in effective amounts to subjects in need of treatment.
Career Highlights
Lavery is currently associated with Axcella Health Inc., a company dedicated to advancing health through innovative therapies. Her role at Axcella Health allows her to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Karen has collaborated with talented professionals, including Revati Wani and Alison Schecter. These collaborations have further enhanced her research and development efforts in the field.
Conclusion
Karen Lavery's innovative work in developing amino acid compositions for treating post-acute sequelae of COVID-19 showcases her dedication to improving health outcomes. Her contributions are vital in the ongoing fight against the effects of this pandemic.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile